RAP 0.00% 20.5¢ resapp health limited

Insto will more than likely buy for potential revenue (like FIL...

  1. 26,799 Posts.
    lightbulb Created with Sketch. 1737
    Insto will more than likely buy for potential revenue (like FIL has) with telehealth and respiratory disease companies the two of the sectors (after vaccine companies) to be invest in during the COVID-19 but after COVID-19 they will be the two main sectors all investor will look at......
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.